Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)

Abstract Background Despite improvements in medical care, patients with advanced cancer still experience substantial symptom distress. There is increasing interest in the use of medicinal cannabinoids but little high-quality evidence to guide clinicians. This study aims to define the role of a 1:1 d...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Główni autorzy: Janet Hardy, Alison Haywood, Gauri Gogna, Jennifer Martin, Patsy Yates, Ristan Greer, Phillip Good
Format: Artigo
Język:Inglês
Wydane: BMC 2020-07-01
Seria:Trials
Hasła przedmiotowe:
Cannabis
Cannabidiol
Cancer
Symptom control
RCT
Palliative care
Dostęp online:http://link.springer.com/article/10.1186/s13063-020-04541-6
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy